Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits

NCT ID: NCT04746469

Last Updated: 2022-09-13

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 2500 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-09-02
• Study Completion Date: 2022-08-01

Brief Summary

As a part of UCLA Health's continued goal of improving patient care the investigators are updating our mailing campaign for our FIT Kit colorectal cancer screening that the investigators administer 2 times per year to include an automated phone call reminder to patients who are overdue for average-risk colorectal cancer screening and enrolled in a mailed FIT program. This will help the investigators evaluate if automated phone calls are effective at improving compliance with CRC screening, in addition to mailed FIT and embedded electronic health record (EHR) portal messages to patients.

Detailed Description

UCLA Health has a biannual mailed FIT program designed to capture patients overdue for CRC screening who are average-risk for CRC. With every campaign, the investigators attempt to improve the return rates for patients receiving the FIT Kits. For the current campaign, all patients enrolled will receive usual care and the investigators are delivering an automated phone call to half the eligible patients reminding them to return their FIT kits and prompting them to request a new kit if needed. The investigators will investigate if this intervention increases the number of patients who complete the mailed Fit Kit or any type of CRC screening over a 6-month follow up period. This quality improvement project will help the investigators improve the processes of care for the patients, and community. If this phone call is successful the investigators will likely expand it to the entire population in future FIT Kit mailer campaigns. However, if it is not effective this will help the investigators minimize the number of calls/interventions the investigators send to patients and will hopefully allow for more useful outreach to patients in the future.

Conditions

Colorectal Cancer Screening

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SCREENING
• Blinding Strategy: NONE

Study Groups

Control

This group will receive standard FIT mailer protocol (includes mailed FIT kit plus standardized messaging via EHR portal)

Group Type: NO_INTERVENTION

No interventions assigned to this group

Intervention

This group will receive standard FIT mailer protocol (as above) PLUS delayed automated phone reminder

Group Type: EXPERIMENTAL

Delayed automated phone call

Intervention Type: BEHAVIORAL

Cipher provides automated phone calls to patients; in this case the script for Cipher was modified to provide patients a reminder to return FIT kits, allow patients to request a new kit in case they need a replacement, and to allow patients to provide information if they already completed CRC screening

Interventions

Delayed automated phone call

Cipher provides automated phone calls to patients; in this case the script for Cipher was modified to provide patients a reminder to return FIT kits, allow patients to request a new kit in case they need a replacement, and to allow patients to provide information if they already completed CRC screening

Intervention Type: BEHAVIORAL

Other Intervention Names

Cipher phone reminder

Eligibility Criteria

Inclusion Criteria

• Overdue for average-risk colorectal cancer screening
• Active primary care provider at UCLA seen within last 3 years

Exclusion Criteria

• Inactive mychart status at time of enrollment
• Died within follow-up period
• Received FIT kit in prior 6 months

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of California, Los Angeles

OTHER

Sponsor Role: lead

Responsible Party

Daniel M. Croymans, MD, MBA, MS

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

UCLA Health Department of Medicine, Quality Office

Los Angeles, California, United States

Countries

United States

Other Identifiers

IRB #19-001418

Identifier Type: -

Identifier Source: org_study_id